Chase Investment Counsel Corp Has $1.03 Million Stake in Crocs, Inc. (NASDAQ:CROX)

Chase Investment Counsel Corp raised its stake in Crocs, Inc. (NASDAQ:CROX) by 27.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,000 shares of the textile maker’s stock after purchasing an additional 2,400 shares during the period. Chase Investment Counsel Corp’s holdings in Crocs were worth $1,027,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in CROX. AQR Capital Management LLC grew its position in Crocs by 141.1% in the 3rd quarter. AQR Capital Management LLC now owns 720,554 shares of the textile maker’s stock worth $63,574,000 after purchasing an additional 421,712 shares in the last quarter. Fuller & Thaler Asset Management Inc. purchased a new position in Crocs in the third quarter valued at about $34,823,000. Assenagon Asset Management S.A. lifted its stake in shares of Crocs by 60.1% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,024,452 shares of the textile maker’s stock valued at $90,387,000 after buying an additional 384,390 shares in the last quarter. BW Gestao de Investimentos Ltda. purchased a new stake in shares of Crocs during the 3rd quarter valued at approximately $17,646,000. Finally, Landscape Capital Management L.L.C. purchased a new stake in shares of Crocs during the 3rd quarter valued at approximately $11,216,000. 93.44% of the stock is owned by institutional investors.

Insider Activity at Crocs

In other Crocs news, Director Ian Bickley sold 16,785 shares of the firm’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $120.05, for a total transaction of $2,015,039.25. Following the completion of the sale, the director now directly owns 31,815 shares in the company, valued at approximately $3,819,390.75. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, Director Ian Bickley sold 16,785 shares of Crocs stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $120.05, for a total value of $2,015,039.25. Following the completion of the sale, the director now directly owns 31,815 shares in the company, valued at $3,819,390.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John B. Replogle purchased 1,972 shares of Crocs stock in a transaction dated Thursday, March 14th. The stock was bought at an average price of $126.75 per share, with a total value of $249,951.00. Following the completion of the purchase, the director now directly owns 3,153 shares of the company’s stock, valued at $399,642.75. The disclosure for this purchase can be found here. Insiders sold a total of 39,867 shares of company stock valued at $4,786,276 in the last three months. Company insiders own 2.69% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on CROX shares. OTR Global raised shares of Crocs from a “mixed” rating to a “positive” rating in a report on Thursday, April 11th. KeyCorp upped their target price on shares of Crocs from $130.00 to $149.00 and gave the stock an “overweight” rating in a report on Thursday, March 21st. B. Riley increased their price target on shares of Crocs from $95.00 to $122.00 and gave the stock a “neutral” rating in a report on Wednesday, April 10th. UBS Group increased their price target on shares of Crocs from $117.00 to $124.00 and gave the stock a “neutral” rating in a report on Tuesday, April 23rd. Finally, Barclays started coverage on shares of Crocs in a report on Monday, April 1st. They issued an “overweight” rating and a $167.00 price target on the stock. Four analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $141.55.

Crocs Trading Up 1.6 %

CROX traded up $2.03 during trading on Monday, hitting $127.43. 372,465 shares of the stock traded hands, compared to its average volume of 1,387,964. The firm has a market capitalization of $7.74 billion, a P/E ratio of 9.99, a price-to-earnings-growth ratio of 1.58 and a beta of 2.01. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.30 and a quick ratio of 0.75. The firm has a 50-day moving average of $128.31 and a 200 day moving average of $107.75. Crocs, Inc. has a 12-month low of $74.00 and a 12-month high of $146.79.

Crocs (NASDAQ:CROX) last posted its earnings results on Thursday, February 15th. The textile maker reported $2.58 EPS for the quarter, topping the consensus estimate of $2.38 by $0.20. Crocs had a net margin of 20.00% and a return on equity of 61.97%. The firm had revenue of $960.10 million during the quarter, compared to analysts’ expectations of $958.39 million. During the same period last year, the company posted $2.65 EPS. The company’s quarterly revenue was up 1.6% compared to the same quarter last year. Equities research analysts anticipate that Crocs, Inc. will post 12.44 EPS for the current year.

About Crocs

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.